Novo says Wegovy lowered BMI and obesity rates in trial of children under 12
Novo says a trial found Wegovy injections lowered BMI and obesity rates in children; the drug is approved for obesity treatment from age 12, but no medications are currently approved for children under 12.Novo said a trial found that Wegovy injections lowered BMI and obesity rates in children. Wegovy is already approved to treat obesity in children aged 12 and older. The supplied report says there are currently no approved medications for children under 12.
cnbc.com (English) ↗+ Save